Achilles Therapeutics plc (ACHL) Financials
ACHL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 175.3 million | 21.9 million |
2023-06-30 | 197.9 million | 24.1 million |
2023-03-31 | 207.6 million | 22.5 million |
2022-12-31 | 220.4 million | 23.3 million |
ACHL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 1.0 million | ? |
2023-06-30 | -17946 | 1701 |
2023-03-31 | -18307 | 1652 |
2022-12-31 | -21.8 million | 1.7 million |
ACHL Net Income
No data available :(
ACHL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 140.1 million | - | 7.4 million |
2023-06-30 | 143.7 million | - | 8.6 million |
2023-03-31 | 158.5 million | - | 7.6 million |
2022-12-31 | 173.3 million | - | 8.6 million |
ACHL Shares Outstanding
ACHL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 61383 | 14.7 million | 4.4 million | - |
2023-06-30 | 537 | 13.8 million | 4.3 million | - |
2023-03-31 | 454 | 13.9 million | 4.7 million | - |
2022-12-31 | 2.1 million | 18.9 million | 4.0 million | - |
ACHL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1.2 million |
2023-06-30 | - | 1.3 million |
2023-03-31 | - | - |
2022-12-31 | - | 837227 |
ACHL
Price: $0.78
52 week price:
Earnings Per Share: -1.74 USD
P/E Ratio: -0.50
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 354400
Market Capitalization: 35.3 million